Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 11, 2012, Pages 1063-1070

  Morgan, Shirlony ^a,b   Kemp, Paul ^c   Booij, Jan ^d   Costa, Durval C ^e   Padayachee, Shalandran ^b   Lee, Lean ^b   Barber, Christopher ^f   Carter, Janet ^g,h   Walker, Zuzana ^b,h  

^a CENTRAL AND NORTH WEST LONDON NHS FOUNDATION TRUST   (United Kingdom)

^b St Margaret's Hospital   (United Kingdom)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e CHAMPALIMAUD CENTRE FOR THE UNKNOWN   (Portugal)

^f PRINCESS ALEXANDRA HOSPITAL NHS TRUST   (United Kingdom)

^g NORTH EAST LONDON NHS FOUNDATION TRUST   (United Kingdom)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE TRANSPORTER; IODINE 123;

AGED; ALZHEIMER DISEASE; ARTICLE; BRADYKINESIA; BRAIN RADIOGRAPHY; CAUDATE NUCLEUS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; DISEASE SEVERITY; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; MALE; NEUROIMAGING; PRIORITY JOURNAL; PROTEIN BINDING; PUTAMEN; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VISUAL ANALOG SCALE;

EID: 84867398911     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-302577     Document Type: Article

References (43)

1. Seelaar H, Rohrer JD, Pijnenburg YA, et al. Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry 2011;82:476-86.
2. Rohrer JD, Lashley T, Schott JM, et al. Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain 2011;134:2565-81.
3. Mackenzie IR, Neumann M, Bigio EH, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 2010;119:1-4.
4. Pijnenburg YA, Gillissen F, Jonker C, et al. Initial complaints in frontotemporal lobar degeneration. Dement Geriatr Cogn Disord 2004;17:302-6. (Pubitemid 38721146)
5. Graham A, Davies R, Xuereb J, et al. Pathologically proven frontotemporal dementia presenting with severe amnesia. Brain 2005;128:597-605. (Pubitemid 40380194)
6. Walker Z, Jaros E, Walker RW, et al. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. J Neurol Neurosurg Psychiatry 2007;78:1176-81. (Pubitemid 350057277)
7. McKeith I, O'Brien J, Walker Z, et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol 2007;6:305-13. (Pubitemid 46367938)
8. Walker Z, Costa DC, Walker RW, et al. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry 2002;73:134-40.
9. Claassen DO, Parisi JE, Giannini C, et al. Frontotemporal dementia mimicking dementia with Lewy bodies. Cogn Behav Neurol 2008;21:157-63.
10. Le Ber I, Camuzat A, Hannequin D, et al. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. Brain 2008;131:732-46. (Pubitemid 351294727)
11. Pasquier F, Lebert F, Lavenu I, et al. The clinical picture of frontotemporal dementia: diagnosis and follow-up. Dement Geriatr Cogn Disord 1999;10 (Suppl 1):10-14. (Pubitemid 29348608)
12. Diehl-Schmid J, Schulte-Overberg J, Hartmann J, et al. Extrapyramidal signs, primitive reflexes and incontinence in fronto-temporal dementia. Eur J Neurol 2007;14:860-4. (Pubitemid 47106763)
13. Aries MJ, Le BN, Debruyne H, et al. Relation between frontal lobe symptoms and dementia severity within and across diagnostic dementia categories. Int J Geriatr Psychiatry 2010;25:1186-95.
14. Johns EK, Phillips NA, Belleville S, et al. Executive functions in frontotemporal dementia and Lewy body dementia. Neuropsychology 2009;23:765-77.
15. Links KA, Merims D, Binns MA, et al. Prevalence of primitive reflexes and Parkinsonian signs in dementia. Can J Neurol Sci 2010;37:601-7.
16. Looi JC, Walterfang M, Styner M, et al. Shape analysis of the neostriatum in subtypes of frontotemporal lobar degeneration: neuroanatomically significant regional morphologic change. Psychiatry Res 2011;191:98-111.
17. Looi JC, Walterfang M, Styner M, et al. Shape analysis of the neostriatum in frontotemporal lobar degeneration, Alzheimer's disease, and controls. Neuroimage 2010;51:970-86.
18. Whitwell JL, Jack CR Jr, Senjem ML, et al. MRI correlates of protein deposition and disease severity in postmortem frontotemporal lobar degeneration. Neurodegener Dis 2009;6:106-17.
19. Rabinovici GD, Seeley WW, Kim EJ, et al. Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen 2007;22:474-88.
20. Josephs KA, Ahmed Z, Katsuse O, et al. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. J Neuropathol Exp Neurol 2007;66:142-51. (Pubitemid 46208735)
21. Mann DM, South PW, Snowden JS, et al. Dementia of frontal lobe type: neuropathology and immunohistochemistry. J Neurol Neurosurg Psychiatry 1993;56:605-14. (Pubitemid 23203757)
22. Mackenzie IR, Baker M, Pickering-Brown S, et al. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain 2006;129:3081-90. (Pubitemid 44684527)
23. Diehl-Schmid J, Grimmer T, Drzezga A, et al. Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study. Neurobiol Aging 2007;28:42-50. (Pubitemid 44791637)
24. Jeong Y, Cho SS, Park JM, et al. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients. J Nucl Med 2005;46:233-9. (Pubitemid 43073429)
25. Rinne JO, Laine M, Kaasinen V, et al. Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia. Neurology 2002;58:1489-93. (Pubitemid 34552954)
26. Sedaghat F, Gotzamani-Psarrakou A, Dedousi E, et al. Evaluation of dopaminergic function in frontotemporal dementia using I-FP-CIT single photon emission computed tomography. Neurodegener Dis 2007;4:382-5. (Pubitemid 47123464)
27. Sperfeld AD, Collatz MB, Baier H, et al. FTDP-17: an early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation. Ann Neurol 1999;46:708-15. (Pubitemid 29518131)
28. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-54.
29. Booij J, Kemp P. Dopamine transporter imaging with [(123)I]FP-CIT SPECT: potential effects of drugs. Eur J Nucl Med Mol Imaging 2008;35:424-38.
30. Booij J, de JJ, de BK, et al. Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects. J Nucl Med 2007;48:359-66.
31. Darcourt J, Booij J, Tatsch K, et al. EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporterligands, version 2. Eur J Nucl Med Mol Imaging 2011;38:786-7.
32. Strauss E, Sherman EMS, Spreen OA. Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York, New York: Oxford University Press, 2006:506e12; 657-67.
33. Knopman DS, Boeve BF, Parisi JE, et al. Antemortem diagnosis of frontotemporal lobar degeneration. Ann Neurol 2005;57:480-8. (Pubitemid 40471156)
34. Kelley BJ, Haidar W, Boeve BF, et al. Prominent phenotypic variability associated with mutations in Progranulin. Neurobiol Aging 2009;30:739-51.
35. Leverenz JB, Yu CE, Montine TJ, et al. A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology. Brain 2007;130:1360-74. (Pubitemid 47355959)
36. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863-72. (Pubitemid 43970103)
37. Burke JF, Albin RL, Koeppe RA, et al. Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography. Brain 2011;134:1647-57.
38. Padovani A, Agosti C, Premi E, et al. Extrapyramidal symptoms in frontotemporal dementia: prevalence and clinical correlations. Neurosci Lett 2007;422:39-42. (Pubitemid 47077572)
39. Espay AJ, Litvan I. Parkinsonism and frontotemporal dementia: the clinical overlap. J Mol Neurosci 2011;45:343-9.
40. Rascovsky K, Hodges JR, Kipps CM, et al. Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alzheimer Dis Assoc Disord 2007;21:S14-18. (Pubitemid 350307439)
41. Sjogren M, Minthon L, Passant U, et al. Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease. Neurobiol Aging 1998;19:379-84. (Pubitemid 29065486)
42. Frisoni GB, Pizzolato G, Bianchetti A, et al. Single photon emission computed tomography with [99Tc]-HM-PAO and [123I]-IBZM in Alzheimer's disease and dementia of frontal type: preliminary results. Acta Neurol Scand 1994;89:199-203. (Pubitemid 24133436)
43. National Institute for Health and Clinical Excellence. Dementia: Supporting People with dementia and their Carers in Health and Social Care. NICE Clinical Guideline Number 42. (NICE). London: National Institute for Health and clinical Excellence, 2006.